This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,533.04 firm-fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The contract has an ultimate completion date of December 17, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is a task order issued under that larger IDC. The contract award did not utilize any set-aside designations, indicating open competition.
Generated 3/17/25, 10:04 AM